Compare BioNano Genomics Inc (BNGO) vs Zillow Group Inc Class C (Z) Price & Performance

Bionano Genomics (BNGO) trades at $1.17, down 2.5% today, but maintains a bullish technical signal with strong moving average support. The company shows improving fundamentals with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable with a -109.95% net margin. Recent positive developments include debt retirement and growing adoption of optical genome mapping technology.

BNGO presents a high-risk, high-reward opportunity with analyst consensus leaning bullish (57% buy ratings). The stock trades at attractive valuation multiples (P/S 0.31, P/B 0.36) but faces execution risks in achieving profitability. Key catalysts include continued technology adoption and potential margin improvement, while persistent losses and competitive pressures remain concerns.

Zillow Group Inc. (Z) trades at $32.19 with no daily change, reflecting a bearish technical signal amid ongoing class action lawsuits. The company shows improving fundamentals with revenue growth from $2.2B in 2024 to $2.6B in 2025 and a return to profitability, though net margins remain thin at 2.27%. Valuation ratios are elevated with a P/E of 127.4, while analyst consensus targets $57.67, implying significant upside if legal and operational risks subside.

The stock presents a high-risk, high-reward scenario. Positive earnings beats and projected margin expansion to 2.26% in 2026 support bullish fundamentals, but legal overhangs and negative cash flow trends pose near-term headwinds. Institutional sentiment is mixed with 46% buy ratings, suggesting cautious optimism contingent on resolution of litigation and execution on growth initiatives.